Mingfu Wu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Liru Xue (11 shared papers)Yingying Chen (6 shared papers)Juncheng Wei (11 shared papers)Shixuan Wang (14 shared papers)Qingqing Zhu (4 shared papers)Tian Wang (6 shared papers)Ding Ma (14 shared papers)Zhiqiang Han (5 shared papers)
- Journals
- Frontiers in Oncology (2 papers)BMC Cancer (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Frontiers in Pediatrics (1 paper)Advanced Healthcare Materials (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Mingfu Wu
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 166
- Immunology 184
- Oncology 222
- Cell Biology 108
- Molecular Biology 445
Countries citing papers authored by Mingfu Wu
This map shows the geographic impact of Mingfu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfu Wu more than expected).
Fields of papers citing papers by Mingfu Wu
This network shows the impact of papers produced by Mingfu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfu Wu. The network helps show where Mingfu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. | 2008 | 138 |
| 2 | 2010 | 132 | |
| 3 | 2008 | 77 | |
| 4 | 2021 | 73 | |
| 5 | 2022 | 64 | |
| 6 | 2019 | 63 | |
| 7 | 2021 | 61 | |
| 8 | 2007 | 54 | |
| 9 | 2019 | 44 | |
| 10 | 2019 | 37 | |
| 11 | 2007 | 33 | |
| 12 | 2020 | 32 | |
| 13 | 2019 | 29 | |
| 14 | 2022 | 26 | |
| 15 | 2016 | 26 | |
| 16 | 2014 | 24 | |
| 17 | 2022 | 23 | |
| 18 | 2021 | 20 | |
| 19 | 2010 | 18 | |
| 20 | 2005 | 18 |
About Mingfu Wu
Mingfu Wu is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Biomedical Engineering and Oncology, having authored 72 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Neonatal and fetal brain pathology (4 papers), Axon Guidance and Neuronal Signaling (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Pelvic floor disorders treatments (3 papers) and Birth, Development, and Health (3 papers). The work is most often cited by research in Cancer Research (166 citations), Immunology (184 citations), Oncology (222 citations), Cell Biology (108 citations) and Molecular Biology (445 citations). Mingfu Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liru Xue, Yingying Chen, Juncheng Wei, Shixuan Wang, Qingqing Zhu, Tian Wang, Ding Ma, Zhiqiang Han, Anping Song and Yanzhi Feng. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, European Journal of Clinical Microbiology & Infectious Diseases, Frontiers in Pediatrics and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.